Page last updated: 2024-11-03

riluzole and Hematologic Diseases

riluzole has been researched along with Hematologic Diseases in 1 studies

Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.

Hematologic Diseases: Disorders of the blood and blood forming tissues.

Research Excerpts

ExcerptRelevanceReference
"This international, open-label, multicentre extension of riluzole pivotal studies was designed to assess the long-term safety of riluzole in the treatment of amyotrophic lateral sclerosis (ALS)."9.10Long-term safety of riluzole in amyotrophic lateral sclerosis. ( Bejuit, R; Bensimon, G; Debove, C; Lacomblez, L; Leigh, PN; Meininger, V; Truffinet, P, 2002)
"This international, open-label, multicentre extension of riluzole pivotal studies was designed to assess the long-term safety of riluzole in the treatment of amyotrophic lateral sclerosis (ALS)."5.10Long-term safety of riluzole in amyotrophic lateral sclerosis. ( Bejuit, R; Bensimon, G; Debove, C; Lacomblez, L; Leigh, PN; Meininger, V; Truffinet, P, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lacomblez, L1
Bensimon, G1
Leigh, PN1
Debove, C1
Bejuit, R1
Truffinet, P1
Meininger, V1

Trials

1 trial available for riluzole and Hematologic Diseases

ArticleYear
Long-term safety of riluzole in amyotrophic lateral sclerosis.
    Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases, 2002, Volume: 3, Issue:1

    Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Canada; Consumer Product Safety; Europe; Female; Hematol

2002